Home/Filings/4/0001578563-23-000073
4//SEC Filing

Bihl Anthony P III 4

Accession 0001578563-23-000073

CIK 0001665988other

Filed

Aug 21, 8:00 PM ET

Accepted

Aug 22, 6:20 PM ET

Size

7.2 KB

Accession

0001578563-23-000073

Insider Transaction Report

Form 4
Period: 2023-08-18
Bihl Anthony P III
DirectorInterim CEO
Transactions
  • Purchase

    Class A Common Stock

    2023-08-18$4.14/sh+13,290$55,005138,290 total
  • Purchase

    Class A Common Stock

    2023-08-18$4.14/sh+26,595$110,07126,595 total(indirect: By Trust)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $3.89 to $4.405, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  • [F2]Reflects shares directly held by The Irene A. Bihl Revocable Trust of which the Reporting Person and his spouse are trustees and among the beneficiaries. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Issuer

Bioventus Inc.

CIK 0001665988

Entity typeother

Related Parties

1
  • filerCIK 0001432665

Filing Metadata

Form type
4
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 6:20 PM ET
Size
7.2 KB